What have we learned from 10-k 1. P2b results are

New Post Public Reply Private Reply Replies (1) Message Board
grotty
401
What have we learned from 10-k
1. P2b results are available. We don’t know how much we owe CRO. We also don’t know what the results say. Good or bad.
2. Some BP is interested in B-OM. Doing DD.
Everything else seems boiler plate to me.
Am I missing anything?

My conclusion: Aspire has no choice but to buy more stock to protect their investment unless a partnership is finalized.

Anyone else have thoughts?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials